Related Experiment Video

Updated: May 21, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Significant response to gemcitabine monotherapy in primary pleural epithelioid angiosarcoma

Kazuya Tsubouchi, Hiroshige Yoshioka, Tadashi Ishida

    Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
    |June 23, 2012
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
    07:55

    Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

    Published on: April 11, 2018

    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
    10:27

    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

    Published on: July 25, 2020

    Related Experiment Videos

    Last Updated: May 21, 2026

    Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
    04:04

    Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

    Published on: February 12, 2017

    Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
    07:55

    Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

    Published on: April 11, 2018

    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
    10:27

    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

    Published on: July 25, 2020

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...

    Articles linked to this work by shared authors, journal, and citation graph.

    Adjuvant chemotherapy intensity and prognosis in completely resected high-grade neuroendocrine lung carcinoma: a post hoc analysis of JCOG1205/1206.

    Lung cancer (Amsterdam, Netherlands)·2026

    Clinical Outcomes and Acute Exacerbation Incidence in Combined Pulmonary Fibrosis and Emphysema.

    Respirology (Carlton, Vic.)·2026

    Prediction of therapeutic effect of antifibrotic therapy for idiopathic pulmonary fibrosis using quantitative CT texture analysis.

    Respiratory medicine·2026

    AGTR1 signaling contributes to tumor immunity and therapy response in non-small cell lung cancer.

    Molecular therapy. Oncology·2026

    Efficacy and safety of an intravenous amikacin-containing regimen as initial therapy in Mycobacterium avium complex pulmonary disease.

    Journal of clinical tuberculosis and other mycobacterial diseases·2026

    Atezolizumab + Chemotherapy in Older Patients With Lung Cancer in Japan.

    Cancer science·2026

    Prognostic Significance of Spread Through Airspaces (STAS) in Stage Ia/bN0 Non-small Cell Lung Cancer - An Evaluation in the JCOG0802/WJOG4607L Clinical Trial Patients.

    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026

    Clinical Responses to Tarlatamab Among Patients with Pulmonary Carcinoid.

    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026

    Tumor mutational burden as a predictor of immune-related adverse events in patients with advanced non-small cell lung cancer receiving immune checkpoint inhibitors: a Brief Report.

    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026

    Lung Cancer Patient Advocacy Progress and New Challenges Since 2006.

    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026

    Comprehensive Patient Reported Outcomes (PROs) from NRG Oncology/Alliance LU005: A Randomized Trial Of Chemoradiation +/- Atezolizumab In Limited-Stage Small Cell Lung Cancer.

    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026

    Bridging evidence and practice: international multidisciplinary consensus on non-metastatic NSCLC.

    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us